References
- Richard J, Lingvay I. Hepatic steatosis and type 2 diabetes: current and future treatment considerations. Expert Rev Cardiovasc Ther. 2011;9(3):321-8. https://doi.org/10.1586/erc.11.15
- Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?. World J Gastroenterol. 2014;20(27):9072-89. https://doi.org/10.3748/wjg.v20.i27.9072
- Lee DH, Han JM, Yang WM. The effects of Atractylodes japonica Koidz. on type 2 diabetic rats. J Korean Med. 2015;35(1):75-85.
- Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Prattey RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930-5. https://doi.org/10.1210/jcem.86.5.7463
- Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA. 2011;108(39):16381-5. https://doi.org/10.1073/pnas.1113359108
- Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000;49(12):2063-9. https://doi.org/10.2337/diabetes.49.12.2063
- Mitchell PL, Nachbar R, Lachance D, St-Pierre P, Trottier J, Barbier O, et al. Treatment with a novel agent combining docosahexaenoate and metformin increase protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice. Diabetes Obes Metab. 2017;19(3):313-9. https://doi.org/10.1111/dom.12818
- Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol. 1998;138(3):269-74. https://doi.org/10.1530/eje.0.1380269
- Kwon OJ, Lee SW, Paik SH, Han SR, Ahn YM, Ahn SY, et al. The effects of Platycodi radix on obese type 2 diabetes mouse model induced by high fat, high carbohydrate diet. J Korean Med. 2013;34(1):1-14.
- Lim DW, Bose S, Wang JH, Choi HS, Kim YM, Chin YW, et al. Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways. Sci Rep. 2017;30(7):45425.
- Lim DW, Kim H, Park JY, Kim JE, Moon JY, Park SD, et al. Amomum cardamomum L. ethyl acetate fraction protects against carbon tetrachloride -induced liver injury via an antioxidant mechanism in rats. BMC Complement Altern Med. 2016;16:155. https://doi.org/10.1186/s12906-016-1121-1
- Kobayashi Y, Hara N, Sugimoto R, Mifuji -Moroka R, Tanaka H, Eguchi A, et al. The associations between circulating bile acids and the muscle volume in patients with non-alcoholic fatty liver disease (NAFLD). Intern Med. 2017; 56(7):755-62. https://doi.org/10.2169/internalmedicine.56.7796
- Lee KP, Kim JE, Kim H, Chang HR, Lee DW, Park WH. Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells. BMC Complement Altern Med. 2016;16:306. https://doi.org/10.1186/s12906-016-1292-9
- Um ES, Kim YC. Effect of samhwangsasim-tang and daehwanghwangryunsasim-tang on palmitate-induced lipogenesis in HepG2 cells. J Korean Med. 2016;37(1):62-76. https://doi.org/10.13048/jkm.16007
- Heo J. Translated Dongeuibogam. 1st ed. Seoul: Bubinmunwha. 1999.
- Ulla A, Alam MA, Sikder B, Sumi FA, Rahman MM, Habib ZF, et al. Supplementation of Syzygium cumini seed powder prevented obesity, glucose intolerance, hyperlipidemia and oxidative stress in high carbohydrate high fat diet induced obese rats. BMC Complement Altern Med. 2017;17:289 https://doi.org/10.1186/s12906-017-1799-8
- Huang Q, Wang T, Yang L, Wang HY. Gisenosied Rb2 alleviates hepatic lipid accumulation by resorting autophagy via induction of Sirt1 and activation of AMPK. Int J Mol Sci. 2017; 19(18):E1063.
- Zhang M, Liu C, Hu MY, Zhang J, Xu P, Li F, et al. High-fat diet enhanced retinal dehydrogenase activity, but suppressed retinol dehydrogenase activity in liver of rats. J Pharmacol Sci. 2015;127(4):430-438. https://doi.org/10.1016/j.jphs.2015.03.001
- Gotoh K, Masaki T, Chiba S, Ando H, Fujiwara K, Shimasaki T, et al. Effects of hydrophilic statins on renal tubular lipid accumulation in diet-induced obese mice. Obes Res Clin Pract. 2013;7(5):e342-352. https://doi.org/10.1016/j.orcp.2013.04.001
- Bonora E, Targher G. Increase risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol. 2012;9(7):372-381. https://doi.org/10.1038/nrgastro.2012.79
- Masarone M, Rosato V, Aglitti A, Bucci T, Caruso R, Salvatore T, et al. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. PLOS One. 2017;12(6):e0178473. https://doi.org/10.1371/journal.pone.0178473
- Bastard JP, Maachi M, Lagath C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006; 17(1):4-12.